Deals Shaping The Medical Industry, November 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced September through October 2013.
You may also be interested in...
Amgen detailed plans for increasing sales of drugs acquired in its Horizon transaction and outlined growth opportunities in its R&D pipeline during a rare disease showcase.
Deborah Autor will build on Healthcare Innovation Catalysts’ cross-functional technical expertise, furthering its role as an advisor in the private and public sectors as its first CEO.
Line extension for physician’s brand BrainMD intends to support secretion of glucagon-like peptide-1; research shows AllerPops prebiotic lozenges improved rhinitis allergy symptoms significantly; and Nutramax Laboratories developing Practitioner Formulas supplements with health care professionals.